Thyroid C-cell Tumors: In rodent experiments, semaglutide continues to be shown to trigger thyroid C-cell tumors. It is actually unidentified irrespective of whether this threat relates to humans, but semaglutide is contraindicated in sufferers with a personal or family record of medullary thyroid carcinoma (MTC) or clients with Various Endocrine N